The molecular mechanisms enabling cancer cells to survive loss-of-adhesion-induced apoptosis in the early phases of metastasis remain largely obscure. Interestingly, the overexpression of tissue factor (TF) on tumor cells is associated with successful metastasis and it has now become clear that coagulation factor VIIa (FVIIa), the natural binding partner of TF induces signal transduction in TF-expressing cells. Hence, we investigated the effects of FVIIa-TF interaction on cell survival. We observed that FVIIa, at physiologically relevant concentrations, inhibits cell death and caspase-3 activation induced by serum deprivation and loss of adhesion (lack of integrin signaling) in TF-overexpressing cells, but not in non-TFexpressing cells. This FVIIa effect was not dependent on the formation of the downstream coagulation products FXa or thrombin and was inhibited using an active siteblocked form of FVIIa (FVIIai). FVIIa incubation resulted in the prolonged activation of both the phosphatidylinositide-3-(OH) kinase and p42/p44 MAP kinase pathways, and studies employing pharmacological inhibitors revealed that both the pathways are required for FVIIa-induced cell survival and inhibition of caspase-3 activity. Finally, TF:FVIIa-induced FXa generation dramatically increased cell survival. We propose that FVIIa-induced cell survival may explain why overexpression of TF is associated with successful metastasis.
Introduction
Tissue factor (TF), a 47 kDa transmembrane protein, is mainly known as the primary initiator of the coagulation cascade. Also, the role of TF in metastasis has been attracting widespread interest. The overexpression of TF, up to a 1000-fold increase over normal levels, is a striking feature of metastatic cells upon comparison with nonmetastatic cells (Mueller et al., 1992) . Moreover, TF expression showed to be a significant and independent risk factor for hepatic metastasis in patients with colorectal cancer (Shigemori et al., 1998; Seto et al., 2000) . In experimental models, the introduction of melanoma cells that overexpress TF in severe combined immunodeficient mice promotes efficient hematogeneous metastasis (Mueller et al., 1992) . Finally, inhibition of TF either using antibodies or active-site-blocked FVIIa (FVIIai) impairs experimental metastasis (Mueller and Ruf, 1998) . The molecular basis, however, for this association between TF and successful metastasis remains obscure.
An interesting possibility is that the TF effects in metastasis may be linked to effects on cellular signal transduction. A variety of intracellular signal transduction cascades are activated upon interaction of TF with its natural binding partner factor VIIa (FVIIa) (Versteeg et al., 2001) , and the binding of FVIIa to TF is required for metastasis. The FVIIa:TF complex is thought to target a G-protein-coupled protease-activated receptor (PAR), which has not been conclusively identified but most likely is PAR-2 (Camerer et al., 2000a) . Subsequent cellular events include the activation of p21Ras (Versteeg et al., 2003) and p42/p44 mitogen-activated protein kinase (MAP kinase) pathways (Poulsen et al., 1998; Camerer et al., 1999 Camerer et al., , 2000b Pendurthi et al., 2000; Versteeg et al., 2000) . Furthermore, FVIIa induces the activation of the protein kinase B (PKB) pathway in TFexpressing cells, in turn producing enhanced protein synthesis (Versteeg et al., 2000 (Versteeg et al., , 2002 and is also essential for FVIIa-induced production of IL-8 and other factors (Wang et al., 2002) . Strikingly, both the p42/p44 MAP kinase and the PKB pathways are also known for their capacity to inhibit programmed cell death or apoptosis (Kennedy et al., 1997; Kulik et al., 1997; Bergmann et al., 1998; Kurada and White, 1998) , but a possible link between TF and diminished apoptosis has not been investigated.
The inhibition of apoptosis may obviously be related to adhesion-independent survival and may thus be linked to metastasis. Hence, we investigated the possible connections between FVIIa-induced activation of MAP kinase and PKB, inhibition of apoptosis and adhesionindependent survival. We observed that FVIIa potently inhibits serum deprivation-and loss-of-adhesion-induced apoptosis and caspase-3 activation in BHK cells stably transfected with TF (BHK TF ). This inhibition was not affected by thrombin or FXa inhibitors. Finally, the FVIIa effect on caspase-3 activity is sensitive to inhibitors of the phosphatidylinositide-3-(OH) kinase (PI3 kinase) and p42/p44 MAP kinase pathways. Therefore, we conclude that FVIIa could be a survival factor for TF-expressing cells, mediating the survival of tumor cells during metastasis.
Results

FVIIa inhibits apoptosis induced by serum deprivation
The primary initiator of coagulation, TF, is frequently upregulated on the surface of tumor cells and metastatic cells (Hamada et al., 1996; Vrana et al., 1996; Shigemori et al., 1998; Seto et al., 2000; Ueda et al., 2001) . Complexation of TF with its natural ligand FVIIa leads to the activation of PKB, also known as c-Akt (Versteeg et al., 2000 (Versteeg et al., , 2002 in several cell types. Since PKB has antiapoptotic properties, we decided to investigate the potential of FVIIa to inhibit apoptosis. To this end we used BHK TF , a cell line that highly overexpresses TF (approximately 2 Â 10 6 TF (Poulsen et al., 1998) ). These cells were seeded in 24-well plates and serum starved to induce apoptosis. After 16 h, the cells were treated with 100 nM FVIIa or were left untreated. Cell survival was monitored using a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. Figure 1a shows that incubation with 100 nM FVIIa considerably inhibits serum starvation-induced apoptosis. As expected, FVIIa did not have any effect on non-TFexpressing BHK cells. Subsequent studies exploring the dose-response relationship of FVIIa-induced survival showed that FVIIa inhibition of cell death was detectable at an FVIIa concentration of 1 nM, which is well below the physiological plasma concentration of the zymogen FVII (10 nM) ( Figure 1b ) and above basal concentrations of activated FVII (approximately 10 pM). We concluded that the physiological concentrations of FVIIa, generated during TF exposure, induce cell survival in BHK TF cells.
FVIIa effects on cell survival are independent of FXa or thrombin generation
FVIIa:TF complexation leads to the formation of FXa and thrombin, which may mediate FVIIa effects on cell survival. Since our experimental setup may allow the presence of some traces of the zymogens FX and prothrombin, we tested the influence of such zymogens on our system. Therefore, we preincubated BHK TF cells with 25 U/ml of the specific thrombin-inhibitor hirudin or 200 nM of the FXa-inhibitor tick anticoagulant protein (TAP) prior to the administration of 100 nM FVIIa. These concentrations of TAP and hirudin were previously shown to inhibit potently FXa and thrombin concentrations as high as 100 nM and 5 mM, respectively (Versteeg et al., 2003) . Figure 1c shows that both hirudin and TAP do not abrogate FVIIa-induced inhibition of apoptosis. Hence, the effects of FVIIa on cell survival are independent of downstream coagulation.
FVIIa induces adhesion independence
Loss of adhesion typically results in anoikis, a form of apoptosis. We observed that serum starvation of cells resulted in a significant detachment of cells from the substratum in both FVIIa and non-FVIIa-treated cultures, and that in FVIIa-treated cultures, survival of the suspension cells was enhanced (Figure 2a ). Hence, it was possible that FVIIa treatment of TF-expressing cells did not only inhibit serum starvation-induced apoptosis but also negatively influenced anoikis. To investigate this possibility, we decided to measure cell survival in cells that were grown in suspension. To this end, BHK TF cells were plated in 1% serum-containing medium on poly(2-hydroxyethylmethacrylate (poly-HEMA)-coated 24-well plates, a condition that prevents attachment of cells to the substratum. After 16 h, 100 nM of FVIIa was added and survival was monitored for several days using the MTT assay. As expected, suspension growth resulted in substantially decreased viability in BHK TF cells (Figure 2b) . Strikingly, the addition of FVIIa resulted in some cell growth, although still significantly less when compared to that observed in cells grown on untreated Obviously, adhesion in this system is a somewhat stronger cell survival signal than FVIIa.
FXa and thrombin inhibitors did not have a significant effect on this FVIIa-induced adhesion independence, whereas the absence of TF did not result in an FVIIa-induced survival. Studies exploring the doseresponse relationship of FVIIa-induced adhesion independence demonstrated that the survival effect could be detected at concentrations as low as 5 nM (Figure 2d ). These results suggest that FVIIa can overcome the apoptosis induced by loss of adhesion at physiologically relevant concentrations.
Active site-blocked FVIIa inhibits FVIIa-induced survival
Further support for the specificity of FVIIa effects on survival came from experiments employing the proteolytically inactive form of FVIIa (FVIIai), which acts as a specific FVIIa antagonist (Srensen et al., 1999) . We incubated serum-starved cells for 30 min with 100 nM FVIIai or 1000 nM FVIIai, prior to stimulating cells with Figure 3a shows that 1000 nM of FVIIai potently inhibited FVIIa-induced survival, whereas 100 nM of FVIIai only had a half-maximal effect. To test the potency of FVIIai as an inhibitor for FVIIainduced survival in suspension cells, we again pretreated cells for 30 min with 100 nM FVIIai or 1000 nM FVIIai, prior to stimulating cells with 100 nM FVIIa. Survival was again measured by means of an MTT assay. From Figure 3b , it is clear that FVIIai potently inhibits FVIIainduced survival also in suspension-grown cells. Moreover, FVIIai proved to be much more potent in this system compared that in serum-starved cells that were treated with FVIIa; preincubation of cells with FVIIai concentrations that were as low as the concentrations of FVIIa that were used for stimulation, already inhibited survival to sub-basal levels. In conclusion, the proteolytic activity of FVIIa appears to be mandatory for FVIIa-induced survival.
FVIIa inhibits starvation-and suspension growth-induced caspase-3 activation
One of the major events in programmed cell death is the activation of caspases, which proteolytically cleave targets that play pivotal roles in essential cellular processes. Caspase-3 is a major effector caspase and the level of caspase-3 activation directly corresponds to the amount of apoptosis. To investigate the influence of FVIIa on starvation-induced apoptosis, BHK wild-type cells and BHK TF cells were seeded in six-well plates and subsequently starved in the presence or absence of FVIIa. Cells were lysed at various times and the lysate was analysed on Western blot, using an antibody directed against activated caspase-3. Figure 4a represents a Western blot that shows a time-dependent activation of caspase-3, after 10 h. However, the addition of FVIIa to the medium markedly inhibited starvation-induced caspase-3 activation in BHK TF cells. The levels of TF were not significantly affected by starvation. In wild-type BHK cells, FVIIa did not have any effect, again demonstrating the TF dependence of FVIIa-induced antiapoptotic effects.
Since FVIIa induced survival in cells that were grown in suspension, we also decided to investigate the potential of FVIIa to inhibit caspase-3 activation induced by the loss of adhesion. Therefore, cells were grown in poly-HEMA-coated plates in the presence or absence of FVIIa. The cells were kept in DMEM, supplemented with 1% fetal calf serum (FCS) to ensure that apoptosis was solely induced by loss of adherence and not by serum starvation. Cells were also grown in cell culture plates, in DMEM containing 1% FCS as a negative control for caspase-3 activation. Whereas BHK TF cells grown in tissue culture-treated plates only showed a modest activation of caspase-3 after 16 and 40 h, cells grown in suspension displayed a clearly increased activation of caspase-3 (Figure 4b ). Importantly, although suspension growth significantly affected TF expression, caspase-3 activation was inhibited by FVIIa treatment, suggesting that FVIIa can over-ride anoikis. Again, wildtype BHK cells did not respond to FVIIa with a decreased caspase-3 activation.
FVIIa induces prolonged PKB and MAP kinase activation in suspension cells
Next, we wondered which pathways could be involved in FVIIa-induced cell survival. Various studies have shown the TF-dependent activation of the antiapoptotic kinases MAP kinase and PI3 kinase pathways by FVIIa (Poulsen et al., 1998; Camerer et al., 1999; Versteeg et al., 2000) . In BHK TF cells that were serum starved, FVIIa elicited a strong transient phosphorylation of PKB and MAP kinase (Versteeg et al., 2002) . Therefore, we decided to investigate PKB and MAP kinase phosphorylation in cells lacking adhesion signaling. BHK TF cells were grown in poly-HEMA-coated plates in DMEM containing 1% FCS, TAP and hirudin, and stimulated with FVIIa for various times ( Figure 5 ). Whereas in serum-starved BHK TF cells, PKB has been reported to show a transient phosphorylation between 5 and 20 min after stimulation with FVIIa, incubation of suspension TF cells and wild-type BHK cells were serum starved in DMEM with or without 100 nM FVIIa for various times. Caspase-3 activation was determined on Western blot, using an antibody against activated caspase-3. A short and a long exposure are depicted. Equal loading was verified using an antibody against bactin. TF levels of cells were also measured. (b) BHK TF cells and wild-type BHK cells were grown on cell culture plates (adh) and in suspension in DMEM, supplemented with 1% FCS. At 30 min after the addition of 200 nM TAP and 25 U/ml hirudin, 100 nM FVIIa was added for the times indicated. Caspase-3 activation was determined on Western blot, using an antibody against activated caspase-3. Equal loading was verified using an antibody against bactin. TF levels of cells were also measured cells with this protease led to prolonged activation of PKB. In accordance, MAP kinase showed a prolonged phosphorylation profile as well, when compared to serum-starved cells. This suggests that both MAP kinase and PKB are important in FVIIa-induced survival in suspension-grown BHK TF cells.
FVIIa inhibits caspase-3 activation via the PI3-kinase and MAP kinase pathways
Next, we tested the involvement of the PI3-kinase and MAP kinase pathways in FVIIa-inhibited caspase-3 cleavage. To this end, we preincubated cells with the specific PI3 kinase or MEK inhibitors LY294002 and PD98059, respectively. Whereas FVIIa inhibited caspase-3 activation in this experiment, preincubation with PD98059 or LY294002 abolished the FVIIa-induced effect. (Figure 6a ). To test the specificity of the inhibitors, the levels of phosphorylated PKB and MAP kinase were also determined; PD98059 potently inhibited basal MAP kinase phosphorylation, whereas LY294002 inhibited PKB phosphorylation, demonstrating the specific effects of the inhibitors on FVIIainhibited caspase-3 cleavage. The involvement of the MAP kinase and PI3 kinase pathways in FVIIa-induced cell survival was also verified in cells that were grown in suspension. Figure 6b clearly shows that, as was the case in serum-starved cells, both the inhibitors were capable of reversing the FVIIa-induced effect and again, both PD98059 and LY294002 specifically inhibited MAP kinase and PKB, respectively. However, as was observed in Figure 5 , FVIIa exposure led to a prolonged phosphorylation of PKB and MAP kinase. We conclude that both the MAP kinase and PI3 kinase pathways contribute to the FVIIa-induced cell survival.
FX increases TF:FVIIa-induced survival
Recently, it was suggested that the presence of FX or FXa may dramatically enhance the effects observed after TF:FVIIa complexation (Riewald and Ruf, 2001 ).
To explore this option, we treated BHK TF cells with various concentrations of FVIIa in the presence of FX, administered in a concentration that corresponds to a physiologically relevant one (130 nM). As can be seen in Figure 7a , the presence of 130 nM FX increases survival to maximum levels, already at FVIIa concentrations of 1 nM. The absence of FVIIa did not result in an FXdependent survival, demonstrating that activated FVII is required for this effect, most likely through the conversion of FX into FXa. The sole addition of FXa to these cells did not result in a survival curve similar to that observed after FVIIa addition, showing that survival after simultaneous FVIIa and FX incubation was not exclusively due to FXa generation (Figure 7b) .
Again, we also determined the effects of FXa generation on cells that have been grown in suspension. As can be seen in Figure 7c , simultaneous incubation of cells with FVIIa and 130 nM of FX resulted in increased Figure 5 FVIIa exposure leads to prolonged PKB and MAP kinase phosphorylation. BHK TF cells were grown in DMEM supplemented with 1% FCS, in poly-HEMA-coated six-well plates and preincubated for 30 min with 200 nM TAP and 25 U/ml hirudin prior to stimulation with 100 nM FVIIa for various times. PKB and MAP kinase phosphorylation was determined using phosphospecific antibodies on Western blot Figure 6 MAP kinase and PI-3 kinase contribute to FVIIainduced survival. (a) Cells were serum starved in DMEM containing mock, PD98059 or LY294002. After 30 min, FVIIa was added for 10 h. Caspase-3 activation was determined on Western blot, using antiactivated caspase-3. Equal loading was verified using and antibody against b-actin. (b) For suspension growth, cells were grown for 16 h in DMEM supplemented with 1% FCS, 200 nM TAP and 25 U/ml hirudin, and pretreated with mock PD98059 or LY294002. After 30 min, FVIIa was added for 20 min. Caspase-3 activation was determined on Western blot, using antiactivated caspase-3. PKB and MAP kinase phosphorylation was determined using phosphospecific antibodies. Equal loading was again verified using an antibody against b-actin cell viability, but not at the low concentrations that were shown to be effective in the starvation experiments (Figure 7a ). This could be due to the diminished TF expression observed in cells that were grown in suspension (Figure 4b) . Furthermore, FXa incubation resulted in a potent inhibition of apoptosis, only at high concentrations, that correspond with the physiological concentrations of the zymogen FX. Therefore, we conclude that in both serum-starved cells and in suspension-grown cells, survival is greatly influenced by TF:FVIIa complexation as well as TF:FVIIa-induced FXa generation.
Discussion
Programmed cell death or apoptosis is a complex mechanism that is activated upon DNA damage or absence of essential input signals from growth factors or binding of the cell to the extracellular matrix (Guadagno and Assoian, 1991) . Aberrant regulation of the apoptotic pathways, resulting from mutations or excessive activation of the antiapoptotic pathways is intrinsic to the oncogenic process in general and the early stages of metastasis in particular. The signal transduction pathways involved in antiapoptosis include the PI3 kinase/ PKB and the p42/p44 MAP kinase pathways. Importantly, the interaction of TF has previously been shown to result in the stimulation of both PI3 kinase-and p42/ p44 MAP kinase-dependent signaling (Poulsen et al., 1998; Camerer et al., 1999; Versteeg et al., 2000 Versteeg et al., , 2002 , whereas the TF overexpression is associated with successful metastasis (Mueller et al., 1992; Shigemori et al., 1998; Seto et al., 2000) . Therefore, we investigated the potential of TF overexpression to confer cell survival and inhibition of apoptosis, especially in the context of loss-of-adhesion-induced cell death. We observed that the incubation of TF-overexpressing cells with FVIIa leads to enhanced cell survival, both in serum-starved cells and in cells that lack adhesion signaling. We also show an FVIIa-induced inhibition of caspase-3 activation that, in serum-starved cells, is dependent on the MAP kinase and PKB pathways. Thus FVIIa, present in the bloodstream, may provide important survival signals during the first stages of the metastatic process.
The contribution of TF and FVIIa to the metastatic process is most likely determined by their concentrations. Tumor cells and metastatic cells often overexpress TF levels (Mueller et al., 1992; Shigemori et al., 1998; Seto et al., 2000) , but FVII levels, normally reaching plasma levels of 10 nM, do not allow for much variation. Therefore, it is not likely that enhanced levels of FVII contribute to survival signaling in blood-borne tumor cells. Importantly, we show that cell survival, mediated by FVIIa, occurs at levels that correspond with plasma levels of FVII, being as low as 1 and 5 nM in serumstarved cells and adhesion-deprived cells, respectively. Thus, the overexpression of TF is at least theoretically capable of inducing survival signaling.
We have also shown that the use of active site-blocked FVIIa (FVIIai) prior to exposure of cells to FVIIa potently inhibits FVIIa-induced survival. With regard to serum-starved cells, the inhibition of FVIIa-induced survival by FVIIai was concentration dependent and a 10-fold excess of FVIIai was required to abolish the effect of FVIIai on survival signaling. These data suggest that FVIIai acts as a competitive inhibitor in this experiment. In contrast, FVIIai was much more potent in cells that were grown in suspension. This suggests that the requirement of FVIIa-dependent signal transduction in suspension cells is much higher as compared with serum-starved cells, which would correspond well with a role for FVIIa in the inhibition of anoikis in blood-borne tumor cells, but obviously further experimental work is necessary to substantiate this conclusion. Another interesting phenomenon is the markedly prolonged phosphorylation of PKB and MAP kinase, when compared to the activation profiles observed in serum-starved cells; whereas the latter are very transient and are back to basal levels within minutes, FVIIainduced phosphorylation of both key proteins remained elevated for considerable time. Although the molecular basis for this event remains poorly defined, it may explain the robust increase in viability observed in suspension-grown FVIIa-stimulated cells.
It has been a matter of debate, whether FVIIa at physiological levels influences important physiological and biochemical processes such as inflammation, angiogenesis and signal transduction (Riewald and Ruf, 2001 ). Therefore, we have determined the influence of TF:FVIIa-induced FXa generation in our system. Although this generation significantly influenced TF:FVIIa-dependent cell survival, we conclude that the combined action of these coagulation proteases has a greater impact on survival than the sole action of either of these factors.
In conclusion, we have shown that FVIIa induces survival in serum-starved cells and detached cells that overexpress TF. This survival occurs at physiological concentrations of TF and is dependent on the MAP kinase and PI3 kinase pathways. FXa generation positively influences this process. It is tempting to propose that the overexpression of TF on tumor cells and the subsequent enhanced survival signaling may provide an important antiapoptotic signal during the early phases of metastasis and experiments addressing this issue directly are currently under progress.
Materials and methods
Materials
The antibodies raised against activated caspase-3 was purchased from Cell Signaling Technologies, whereas the antibody against b-actin was obtained from Santa Cruz. MTT was obtained from Sigma (St Louis, MO, USA). LY294002 as well as PD98059 were obtained from Alexis. Hirudin was obtained from calbiochem and TAP was a kind gift from Dr George Vlasuk (Corvas International, Inc., San Diego, CA, USA). Recombinant FVIIa was obtained from Novo Nordisk (Bagsvaerd, Denmark) and both purified FX and FXa were obtained from Enzyme Laboratories (South Bend, USA)
Cell culture
Baby hamster kidney cells, either wild type or stably transfected with full-length TF, were maintained in Dulbecco's modified Eagles medium, supplemented with 10% (Gibco) and penicillin/streptomycin, at 371C and 5% CO 2 in a humidified environment. The cells were routinely passaged three times per week. Starvation was carried out in DMEM deprived of FCS for 16 h. PD98059 and LY294002 were preincubated for 30 min in the concentrations indicated. For survival assays and caspase-3 analysis in suspension, the cells were grown in plates that were coated with poly-HEMA; 24-well plates were coated overnight with 1 ml 10 mg/ml poly-HEMA in 100% ethanol.
Survival assay
BHK or BHK
TF cells were seeded in 24-well plates and serum starved for 16 h. Subsequently, when appropriate, the cells were preincubated with 25 U/ml hirudin or 200 nM TAP for 30 min. After that the cells were stimulated with FVIIa. Cell survival was determined at regular intervals, using an MTT assay as described before (Mosmann, 1983; Rubinstein et al., 1990) . Briefly, 0.5 mg/ml MTT was directly added to the media, for 30 min at 371C. Subsequently, the media were aspirated and the cells were lysed in isopropanol/0.04 N HCl. The OD 550 of this solution was determined using an ELISA reader.
Western blotting
After incubation, the cells were kept on ice and washed with ice-cold phosphate-buffered saline (PBS). After that the cells were rapidly harvested by adding 100 ml of heated (951C) sample buffer (125 mM Tris/HCl, pH 6.8; 4% SDS; 2% bmercaptoethanol; 20% glycerol, 1 mg bromophenol blue), lysates were collected by scraping. After a 5 min incubation at 951C, 30 ml of the lysates were loaded onto SDS-PAGE and subsequently transferred onto a PVDF membrane. The membranes were blocked with a tris-buffered saline supplemented with 0.1% Tween-20 (wash buffer) and 2% low-fat milk powder, and incubated with a primary antibody overnight at 41C, diluted 1 : 1000 in wash buffer containing 2.5% BSA. Subsequently, the membranes were incubated with a horseradish peroxidase-conjugated secondary antibody in wash buffer containing 2% lowfat milk powder. The bands were visualized using Lumilight plus s ECL substrate from Roche and a chemiluminescence detector with a cooled CCD camera (Genegnome) from Syngene. The antibody bands were quantified using Genetools from Syngene.
